Business Wire

SKULLY-TECHNOLOGIES

6.11.2018 07:02:11 CET | Business Wire | Press release

Share
First Integrated Smart Helmet Technology on the Global Market to be Presented at EICMA

SKULLY Technologies , designer and manufacturer of augmented reality wearable tech gear will introduce the world’s first integrated smart helmet in market at the industry’s premier event, EICMA in Milan. The SKULLY FENIX AR motorcycle helmet which began shipment is helping to revolutionize rider experiences with a suite of innovative features.

Ivan and Rafael Contreras, successful serial entrepreneur cousins purchased the assets of Skully, Inc., a Silicon Valley start-up which ceased operations in 2016 prior to fulfilling product orders. Ivan brought in a leadership team with deep expertise in manufacturing and technology, named the company SKULLY Technologies, and in less than 18 months, re-engineered the world’s most intelligent motorcycle helmet and began shipping.

The FENIX AR brings motorcyclists a unique, unparalleled experience that offers increased safety and connectivity. Innovative features of the helmet include:

  • Heads-up display features rearview for 360-degree situational awareness.
  • Voice commands operate navigation, music and calls.
  • Over-the-air (OTA) updates for ongoing improvements through automatic downloads ensuring that riders are geared up with the most cutting-edge capabilities.

WHAT: SKULLY Technologies to unveil the FENIX AR to the European market at EICMA, the world’s largest gathering of motorcycle industry leaders, in Milan. The unveiling will be the industry’s first opportunity to see the first fully integrated smart helmet technology that recently began shipping. Additionally, guests will hear from SKULLY Technologies cofounder and CEO with the opportunity for Q&A following the presentation.

WHEN / AGENDA: Wednesday 7th November 2018

  • 11:35AM: Meet executives
  • 11:50AM: Cofounder and CEO of SKULLY Technologies Ivan Contreras reveals FENIX AR followed by Q&A and photo opportunities

WHERE: EICMA Conference
Rho Fiera Milano
Strada Statale 33 del Sempione, 28, Rho, NW part of Milan
Hall 11 Stand I18 @ Torrot / GasGas Exhibit

About SKULLY Technologies

SKULLY Technologies designs and manufacturers AR wearable technology as a part of the personal mobility interconnect. Its first product, the world's most intelligent motorcycle helmet, provides advanced technology to promote a safe, comfortable and connected ride. Headquartered in Atlanta, the new company is led by a team of technology, transportation and motorcycle experts, including majority owners Ivan Contreras, founder and CEO of Torrot/GasGas motorcycle brands, and Rafael Contreras, president of Carbures, aerospace carbon fiber manufacturer, and minority owners Western Technology Investment, a Silicon Valley venture capital firm, and Daniel Reiner, an investor in transportation technologies. For more information, visit www.skullytechnologies.com .

Contact:

ONSITE CONTACT: Torrot / GasGas Joan Rodriguez, +34 662 132 465 jrodriguez@torrot.com or OFFSITE CONTACTS: SKULLY Technologies Diane Maier, +1 770-289-6339 press@skullytechnologies.com or The Blueshirt Group for Muving Ecosystem Katie North, +1 415-217-4963 katie@blueshirtgroup.com

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Data to Be Highlighted in Four Rapid Oral Presentations at the European Society for Medical Oncology (ESMO) Congress 2026 Support Efforts to Improve Outcomes in Difficult-to-Treat Cancers17.7.2026 19:10:00 CEST | Press release

Rapid oral presentations will highlight new Phase 1 data across Incyte’s solid tumor portfolioBoth INCB161734, an investigational, potent, selective and orally bioavailable KRAS G12D inhibitor, and INCA338901, a TGFβR2×PD-1 bispecific antibody, are being evaluated in ongoing Phase 3 programs as first-line treatments for patients with advanced pancreatic ductal adenocarcinoma (PDAC) and microsatellite stable (MSS) colorectal cancer, respectively Incyte (Nasdaq:INCY) today announced that it will highlight data from several programs in its oncology portfolio in six presentations at the European Society of Medical Oncology (ESMO) Congress 2026, being held October 23 - 27, 2026, in Madrid. “The data at ESMO will further illustrate Incyte’s commitment to advancing innovation for patients with cancer,” said Pablo J. Cagnoni, M.D., President, Incyte and Global Head of Research and Development. "Among the presentations are important updates from our KRAS G12D inhibitor in advanced pancreatic ca

STL Expands Its Optical Connectivity Portfolio in the US with the CONCAT Solution17.7.2026 14:24:00 CEST | Press release

STL Optical Connectivity NA, LLC, (STLOC), a U.S. subsidiary of STL (Sterlite Technologies Ltd.) [NSE: STLTECH], a leading connectivity solutions provider for AI-ready digital infrastructure, today announced that it launched its new advanced FTTH solution, CONCAT, after successfully completing field trials on the networks of one of the largest telecom service providers in the United States. Following successful field validation, CONCAT is now available to digital infrastructure providers seeking faster fiber rollouts with reduced deployment complexity and labor. It enables up to 71% in labor cost savings by eliminating most field splicing through factory-assembled, pre-connectorized fiber segments that deliver plug-and-play installation. CONCAT simplifies fiber deployment by shifting critical fiber preparation and termination into a controlled manufacturing environment ensuring consistent quality, faster installation, and lower operational risk in the field. CONCAT solution is ideal fo

Aqemia and Sanofi Expand Their Research Collaboration17.7.2026 12:30:00 CEST | Press release

A new target nomination and a milestone payment mark the next step of the multi-year partnership first announced in December 2023 Aqemia, the drug invention company combining generative AI and quantum-inspired physics to invent small molecule drugs, today announced the expansion of its multi-year research collaboration with the global pharmaceutical company, Sanofi. The expansion is marked by the nomination of a new therapeutic target and an additional payment. The collaboration, first announced in December 2023, makes Aqemia eligible to receive up to a total of $140 million in upfront and milestone payments across programs. It spans the drug discovery journey from the identification of the very first hits to the selection of a development candidate. Aqemia leverages Qemi, its proprietary physics-based generative AI platform, to design novel molecules addressing Sanofi’s targets of choice, working in close collaboration with Sanofi scientific teams. Sanofi leads wet lab research, devel

China's ~$900B Live-Commerce Market Now Approaches US E-Commerce Scale17.7.2026 12:30:00 CEST | Press release

The consumer habits reshaping global retail were built in the East — and most Western shoppers haven't yet adopted them. NIQ report shows that brands still treating live, social, and quick commerce as "emerging" risk being left behind. The center of gravity in global retail has shifted East. The formats now driving the fastest growth in global retail (live shopping, social commerce, and delivery in minutes) were pioneered and scaled in Asia, and most Western consumers have yet to adopt them. According to NIQ (NYSE: NIQ), a leading consumer intelligence company, in its global report The Commerce Revolution: Where East Meets West, the gap between East and West is still vast. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717253489/en/ China´s USD 900bn live shopping boom now approaches the scale of the US E-commerce The scale is already substantial. China's live-commerce market alone was worth roughly $900 billion in 2025,

Ant International’s Alipay+ Connects Argentina's National QR Payment Scheme via PVS,Enabling for Cross-Border Digital Payment Nationwide at Millions of Merchants17.7.2026 12:17:00 CEST | Press release

Alipay+, a global digital payment gateway under Ant International, today announced that it will enable global travellers to make QR code payments at millions of merchants across Argentina through integration with the country's national QR payment scheme Transferencias 3.0, in partnership with PVS, a fintech company specialized in developing customized payment solutions in Latin America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260717276406/en/ By connecting to Argentina's national QR payment scheme, Alipay+ now enables global travellers in the country to make convenient QR code payments at merchants nationwide. This service helps to enhance global travellers' travel experiences in Argentina, allowing them to pay seamlessly at restaurants, malls and tourist attractions. Using an Alipay+ partner payment app, they can now scan the national QR code displayed at all merchants to make cross-border payments across Argentina,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye